Cannabis in Australia

Cannabis in Australia

The medicinal cannabis market in Australia is expected to be worth AUD582.1 million by 2024, serving 380,000 patients, up from 340,000 in 2023. As more individuals seek relief from anxiety and chronic pain, medical cannabis is becoming more widely known. Applications for special access have increased more than 100% in two years. As more competitors join the market and with imports representing 80% of the market, local manufacturing is developing as it increases competitiveness and improves produ...

Euromonitor International's Cannabis in Australia market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It provides the latest retail sales data (historic date range), allowing you to identify the key cannabinoid categories driving growth. It outlines the regulatory, cultural and commercial context and offers strategic analysis of key factors influencing the market – legislative developments both current and future, economic/lifestyle influences, illicit consumption, product innovation, distribution and pricing trends. Forecasts to 2029 illustrate how the market is set to expand and change.

Product coverage: Adult-Use Cannabis, CBD & Other Non-Intoxicating Cannabinoids, Medical Cannabis.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report??
* Get a detailed picture of the Cannabis market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.